Review the role of lipoprotein(a), apolipoprotein B, and non-HDL cholesterol as cardiovascular disease risk factors. |
|
|
|
|
|
|
Differentiate screening recommendations and methods in lipoprotein measurement. |
|
|
|
|
|
|
Discuss current lipoprotein treatment options for cardiovascular disease risk reduction. |
|
|
|
|
|
|